Scarica l'app Stockscreener
0.3755
0.89%
0.0027
Autonomix Medical Inc Borsa (AMIX) Ultime notizie
AMIX Stock Price, Quote & Chart | AUTONOMIX MEDICAL INC (NASDAQ:AMIX) - ChartMill
Autonomix Medical Announces Abstract Acceptance At Digestive Disease Week 2026 - TradingView
Pancreatic cancer pain study from Autonomix lands DDW 2026 slot - Stock Titan
Autonomix (AMIX) Stock Factory Orders (+0.22%) 2026-04-27Insider Selling - Newser
Autonomix (AMIX) Innovation Pipeline | Autonomix Medical posts narrower loss with 39.7% EPS surpriseATM Offering - Cổng thông tin điện tử Tỉnh Sơn La
Autonomix Medical shares rally on positive pancreatic cancer pain data - MSN
Is Autonomix (AMIX) stock cyclical or defensive | Q1 2026: EPS Exceeds ExpectationsMost Discussed Stocks - Cổng thông tin điện tử tỉnh Lào Cai
Autonomix Medical, Inc. to Present Long-Term Clinical Data on Transvascular RF Ablation for Pancreatic Cancer Pain at ECIO 2026 - Quiver Quantitative
Long-term pancreatic cancer pain study from Autonomix gets Basel stage - Stock Titan
Autonomix (AMIX) Stock: Forming Reversal? (-1.97%) 2026-04-20Risk Management - Xã Thanh Hà
Insider Trends: Can Autonomix Medical Inc scale operations efficiently2026 Trade Ideas & Community Verified Trade Alerts - baoquankhu1.vn
Insider Sell: What analysts say about Autonomix Medical Inc stockStock Surge & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Analyst Downgrade: Does Autonomix Medical Inc meet Warren Buffetts criteria2026 Institutional Moves & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Jobs Data: Is Autonomix Medical Inc a potential multi bagger2026 Market Trends & High Return Stock Watch Alerts - baoquankhu1.vn
Autonomix Medical’s Featured Abstract on Pain Mitigation in Pancreatic Adenocarcinoma to be Presented at SIR 2026 Annual Scientific Meeting - Quiver Quantitative
Autonomix Medical Selected for Featured Abstract and Podium Presentation of Long-Term Pain Mitigation in Pancreatic Cancer at SIR 2026 - Weekly Voice
Autonomix Medical Selected for Featured Abstract and Podium - GlobeNewswire
Whale Trades: What are analysts price targets for Autonomix Medical IncAnalyst Downgrade & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
Is Autonomix (AMIX) Stock Slowing Down | Price at $0.39, Down 1.14%Sell Signals - Newser
Market Outlook: How is Autonomix Medical Inc managing supply chain issues2026 Recap & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
AMIX Stock Analysis: Autonomix Medical Inc. medtech stock at 0.4 gains 3.18 pct - Newser
Aug Big Picture: Is Autonomix Medical Inc a speculative investment2026 Action & High Accuracy Buy Signal Tips - baoquankhu1.vn
RSI Check: What analysts say about Autonomix Medical Inc stockQuarterly Risk Review & Safe Entry Point Identification - baoquankhu1.vn
Meme Stocks: Is Autonomix Medical Inc a potential multi bagger2026 Winners & Losers & Low Risk High Win Rate Picks - baoquankhu1.vn
Autonomix Medical, Inc.: Fundamental Analysis and Financial Ratings | AMIX | US05330T2050 - marketscreener.com
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Market Review: Is Autonomix Medical Inc a speculative investmentOptions Play & Technical Buy Zone Confirmation - baoquankhu1.vn
Hedge Fund Bets: Does Autonomix Medical Inc have a sustainable dividendQuarterly Profit Summary & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Autonomix Medical (AMIX) Stock Price, News & Analysis - MarketBeat
Forecast Cut: Is Autonomix Medical Inc a speculative investment2026 Buyback Activity & Smart Investment Allocation Insights - baoquankhu1.vn
Autonomix Medical to Present at LSI USA '26 - marketscreener.com
Autonomix Medical to Present at LSI USA '26 Conference on Innovative Nerve-Targeted Treatments - Quiver Quantitative
Autonomix Medical to Present at LSI USA ’26 - GlobeNewswire
Medtech summit talk: Autonomix CEO on stage at LSI USA ’26 - Stock Titan
How is Autonomix Medical Inc managing supply chain issues2026 Bull vs Bear & Low Risk High Reward Trade Ideas - baoquankhu1.vn
Autonomix Medical Selected for Best Innovation Competition at CRT 2026 - The Globe and Mail
Autonomix Medical, Inc. Secures Oral Presentation Spot at CRT 2026 for Innovative Nerve-Targeted Technology - Quiver Quantitative
New nerve-targeting tech lands CRT 2026 Best Innovation stage - Stock Titan
Autonomix Medical Selected as Top Abstract at CRT 2026 and Selected for Podium Presentation of Clinical Feasibility and Outcomes of Novel Technique for Transvascular Peripheral RF Nerve Neurolysis - Bitget
Autonomix Medical Selected as Top Abstract at CRT 2026 and - GlobeNewswire
Quarterly Trades: What analysts say about Autonomix Medical Inc stockPortfolio Update Summary & Stock Timing and Entry Methods - baoquankhu1.vn
Autonomix Medical to Present Long-Term Pain Data for Pancreatic Cancer at SSO 2026 - National Today
AMIX Should I Buy - Intellectia AI
Autonomix Medical Launches CEO Corner to Highlight Peer-Reviewed Publication Strategy and Scientific Validation Efforts - geneonline.com
Autonomix Medical Announces Release Of New CEO Corner Segment - TradingView
Autonomix CEO on validating nerve-targeting tech through peer review - Stock Titan
Autonomix Medical Announces Release of New CEO Corner - GlobeNewswire
AMIXAutonomix Medical Inc Latest Stock News & Market Updates - Stock Titan
Is Autonomix Medical Inc. forming a breakout patternJuly 2025 Recap & Low Risk High Win Rate Picks - mfd.ru
Autonomix Medical Selected to Present New Long-Term Pain - GlobeNewswire
Autonomix Medical (NASDAQ:AMIX) Given New $2.00 Price Target at Maxim Group - Defense World
Autonomix Medical (AMIX) Price Target Slashed by Maxim Group | A - GuruFocus
Will Autonomix Medical Inc. stock hit new highs in YEAR2025 Historical Comparison & Step-by-Step Trade Execution Guides - mfd.ru
AMIX PE Ratio & Valuation, Is AMIX Overvalued - Intellectia AI
Trade Report: Is Autonomix Medical Inc a speculative investment2025 Market WrapUp & Weekly Consistent Profit Watchlists - baoquankhu1.vn
1.04%
0.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):